ColombattiR, SainatiL, TrevisanutoD.Anemia and transfusion in the neonate. Semin Fetal Neonatal Med. 2016;21:2-9.
2.
BanerjeeJ, AladangadyN.Biomarkers to decide red blood cell transfusion in newborn infants: biomarkers of blood transfusion. Transfusion. 2014;54:2574-2582.
3.
BeeramMR, KraussDR, RiggsMW.Red blood cell transfusion practices in very low birth weight Infants in 1990s post surfactant era. J Natl Med Assoc. 2001;93:405-409.
4.
CurleyA, StanworthSJ, WilloughbyKet al.Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380:242-251.
5.
MottaM, Del VecchioA, PerroneB, GhirardelloS, RadicioniM.Fresh frozen plasma use in the NICU: a prospective, observational, multicentred study. Arch Dis Child Fetal Neonatal Ed. 201499:F303-308.
6.
StanworthSJ, Grant-CaseyJ, LoweDet al.The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion. 2011;51:62-70.
7.
VenkateshV, KhanR, CurleyA, NewH, StanworthS.How we decide when a neonate needs a transfusion. Br J Haematol. 2013;160:421-433.
8.
NewHV, BerrymanJ, Bolton-MaggsPHBet al.Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016;175:784-828.
9.
Alonso-CoelloP, OxmanAD, MobergJet al.GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089.
10.
WhyteR, KirpalaniH.Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev. 2011;(11):CD000512. doi:10.1002/14651858.CD000512.pub2.
11.
BellEF, StraussRG, WidnessJAet al.Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005;115:1685-1691.
12.
KirpalaniH, WhyteRA, AndersonCet al.The premature infants in need of transfusion (PINT) study: a randomized controlled trial of a restrictive (low)versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149:301-307.
13.
ChenHL, TsengHI, LuCC, YangSN, FanHC, YangRC.Effect of blood transfusions on the outcome of very low body weight preterm infants under two different transfusion criteria. Pediatr Neonatol. 2009;50:110-116.
14.
ConnellyRJ, StoneSH, WhyteRK.Early vs. late red cell transfusion in low birth weight infants. Pediatr Res. 1998;43:170A.
15.
FredricksonLK, BellEF, CressGAet al.Acute physiological effects of packed red blood cell transfusion in preterm infants with different degrees of anaemia. Arch Dis Child Fetal Neonatal Ed. 2011;96:F249-53.
16.
DaniC, PezzatiM, MartelliE, PrussiC, BertiniG, RubaltelliFF.Effect of blood transfusions on cerebral haemodynamics in preterm infants. Acta Paediatr. 2002;91:938-941.
17.
AlkalayAL, GalvisS, FerryDA, SimmonsCF, KruegerRCHemodynamic changes in anemic premature infants: are we allowing the hematocrits to fall too low?Pediatrics. 2003;112:838-845.
18.
NelleM, HöckerC, ZilowEP, LinderkampO.Effects of red cell transfusion on cardiac output and blood flow velocities in cerebral and gastrointestinal arteries in premature infants. Arch Dis Child Fetal Neonatal Ed. 1994;71:F45-8.
19.
WongH, ConnellyR, DayA, FlavinMP.A comparison of high and standard blood transfusion volumes in premature infants. Acta Paediatr. 2005;94:624-625.
20.
MallettLH, GovandeVP, ShettyA, BeeramMR.Safety and efficacy of packed red blood cell transfusions at different doses in very low birth weight infants. Proc Bayl Univ Med Cent. 2016;29:128-130.
21.
PaulDA, LeefKH, LockeRG, StefanoJL.Transfusion volume in infants with very low birth weight: a randomized trial of 10 versus 20 mL/kg. J Pediatr Hematol Oncol. 2002;24:43-46.
22.
DaniC, PerugiS, BenuzziAet al.Effects of red blood cell transfusions during the first week of life on acid-base, glucose, and electrolytes in preterm neonates. Transfusion. 2008;48:2302-2307.
23.
BrunskillSJ, WilkinsonKL, DoreeC, TrivellaM, StanworthS.Transfusion of fresher versus older red blood cells for all conditions. Cochrane Database of Syst Rev. 2015;(5):CD010801. doi:10.1002/14651858.CD010801.pub.
24.
StraussRG, BurmeisterLF, JohnsonKet al.AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion. 1996;36:873-878.
25.
StraussRG, BurmeisterLF, JohnsonK, CressG, CordleD.Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr. 2000;136:215-219.
26.
FergussonD, HuttonB, HoganDLet al.Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA. 2012;308:1443-1451.
27.
LiuEA, ManninoFL, LaneTA.Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr. 1994;125:92-96.
28.
Fernandes da CunhaDH, Nunes Dos SantosAM, KopelmanBIet al.Transfusions of CPDA-1 red blood cells stored for up to 28 days decrease donor exposures in very low-birth-weight premature infants. Transfus Med. 2005;15:467-473.
29.
MoroffG, HolmeS, AuBuchonJP, HeatonWA, SweeneyJD, FriedmanLI.Viability and in vitro properties of AS-1 red cells after gamma irradiation. Transfusion. 1999;39:128-134.
30.
HarteG, PaytonD, CarmodyF, O’ReganP, ThongYH.Graft versus host disease following intrauterine and exchange transfusions for rhesus haemolytic disease. Aust N Z J Obstet Gynaecol. 1997;37:319-322.
BergerRS, DixonSL.Fulminant transfusion-associated graft-versus-host disease in a premature infant. J Am Acad Dermatol. 1989;20:945-950.
33.
ParkmanR, MosierD, UmanskyI, CochranW, CarpenterCB, RosenFS.Graft versus host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med. 1974;290:359-363.
34.
NaimanJL, PunnettHH, LischnerHW, DestineML, AreyJB.Possible graft versus host reaction after intrauterine transfusion for Rh-erythroblastosis fetalis. N Engl J Med. 1969;281:697-701.
35.
JasaniB, RaoS, PatoleS.Withholding feeds and transfusion-associated necrotizing enterocolitis in preterm infants: a systematic review. Adv Nutr. 2017;8:764-769.
36.
DerienzoC, SmithPB, TanakaDet al.Feeding practices and other risk factors for developing transfusion-associated necrotizing enterocolitis. Early Hum Dev. 2014;90:237-240.
37.
DotyM, WadeC, FarrJ, GomezcoelloVC, MartinG, NasrT.Feeding during blood transfusions and the association with necrotizing enterocolitis. Am J Perinatol. 2016;33:882-886.
38.
MenesesJ, FigueredoJ, MacedoA.Does withholding feedings during transfusions decrease the incidence of necrotizing enterocolitis in preterm infants?[Internet]. Pediatric Academic Societies Abstract Archive. http://www.abstracts2view.com/pasall.
39.
BajajM, Lulic-BoticaM, HansonA.Transfusion associated necrotizing enterocolitis in extremely preterm infants: to feed or not to feed? [Internet]. Pediatric Academic Societies Abstract Archive. http://www.abstracts2view.com/pasall.
40.
MohamedA, AyedM, ShahP.Withholding feeds during blood transfusion and risk of transfusion associated necrotizing enterocolitis (TANEC). Paediatr Child Health. 2015;20:62(abstr).
41.
PerciaccanteJV, YoungTE.Necrotizing enterocolitis associated with packed red blood cell transfusions in premature neonates [Internet]. Pediatric Academic Societies Abstract Archive. http://www.abstracts2view.com/pasall.
42.
RindoneS, KneeA, RothsteinR.Assessing the impact of holding feedings during PRBC transfusion on the incidence of transfusion related gut injury (TRAGI) in preterm infants. [Internet]. Pediatric Academic Societies Abstract Archive. http://www.abstracts2view.com/pasall.
43.
JosephsonCD, CaliendoAM, EasleyKAet al.Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants a prospective cohort study. JAMA Pediatr. 2014;168:1054-1062.
44.
DelaneyM, MayockD, KnezevicAet al.Postnatal cytomegalovirus infection: a pilot comparative effectiveness study of transfusion safety using leukoreduced only transfusion strategy. Transfusion. 2016;56:1945-1950.
45.
KimAE, LeeYK, KimKAet al.Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area. J Korean Med Sci. 2006;21:5-10.
46.
EisenfeldL, SilverH, McLaughlinAet al.Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion. 1992;32:205-209.
47.
StanworthSJ, ClarkeP, WattsTet al.Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics. 2009;124:e826-34.
48.
von LindernJS1, van den BrueleT, LoprioreE, WaltherFJ.Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr. 2011 Feb 11;11:16. doi:10.1186/1471-2431-11-16.
Kjeldsen-KraghJ, KillieMK, TomterGet al.A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood. 2007;110:833-839.
BusselJB, ZacharoulisS, KramerK, McFarlandJG, PaulinyJ, KaplanC.Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer. 2005;45:176-183.
54.
GhevaertC, CampbellK, WaltonJet al.Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion. 2007;47:901-910.
55.
te PasAB, LoprioreE, van den AkkerESet al.Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG. Eur J Pediatr. 2007;166:1057-1063.
KumarJ, DuttaS, SundaramV, SainiSS, SharmaRR, VarmaN.Platelet transfusion for PDA closure in preterm infants: a randomized controlled trial. Pediatrics. 2019;143:e20182565.
58.
HambletonG, AppleyardWJ.Controlled trial of fresh frozen plasma in asphyxiated low birth weight infants. Arch Dis Child. 1973;48:31-35.
59.
GroupThe Northern Neonatal Nursing Initiative (NNNI) Trial, ElbourneD.A randomized trial comparing the effect of prophylactic intravenous fresh frozen plasma, gelatin or glucose on early mortality and morbidity in preterm babies. Eur J Pediatr. 1996;155:580-588.
60.
BeverleyDW, Pitts-TuckerTJ, CongdonPJ, ArthurRJ, TateG.Prevention of intraventricular haemorrhage by fresh frozen plasma. Arch Dis Child. 1985;60:710-713.
61.
EkbladH, KeroP, ShafferSG, KorvenrantaH.Extracellular volume in preterm infants: influence of gestational age and colloids. Early Hum Dev. 1991;27:1-7.
62.
ThayyilS, OliveiraV, LallyPJet al.Hypothermia for encephalopathy in low and middle-income countries (HELIX): study protocol for a randomised controlled trial. Trials. 2017;18:432.
63.
PakvasaMA, WinklerAM, HamrickSE, JosephsonCD, PatelRM.Observational study of haemostatic dysfunction and bleeding in neonates with hypoxic-ischaemic encephalopathy. BMJ Open. 2017;7:e013787.
64.
FormanKR, DiabY, WongEC, BaumgartS, LubanNL, MassaroAN.Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study. BMC Pediatr. 2014;14:277.
65.
JacobsSE, BergM, HuntR, Tarnow-MordiWO, InderTE, DavisPG.Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;2013:CD003311. doi:10.1002/14651858.CD003311.pub.
66.
AzzopardiDV, StrohmB, EdwardsADet al.TOBY Study Group: moderate hypothermia to treat perinatal asphyxia encephalopathy. N Engl J Med. 2009;361:1349-1358
67.
SimbrunerG, MittalRA, RohlmannF, Participants.Muche R; neo.nEURO.network TrialSystemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics. 2010;126:e771-8.
68.
SarkarS, BarksJD, BhagatI, DonnSM.Effects of therapeutic hypothermia on multiorgan dysfunction in asphyxiated newborns: whole-body cooling versus selective head cooling. J Perinatol Off J Calif Perinat Assoc. 2009;29:558-563.
69.
ShankaranS, LaptookAR, PappasAet al.Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA. 2014 Dec 24;312(24):2629.
70.
ShankaranS, LaptookAR, PappasAet al.Effect of depth and duration of cooling on death or disability at age 18 months among neonates with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA2017;318:57-67.
71.
BharadwajSK, BhatBV.Therapeutic hypothermia using gel packs for term neonates with hypoxic ischaemic encephalopathy in resource-limited settings: a randomized controlled trial. J Trop Pediatr. 2012;58:382-388.
72.
JoyR, PournamiF, BethouA, BhatVB, BobbyZ.Effect of therapeutic hypothermia on oxidative stress and outcome in term neonates with perinatal asphyxia: a randomized controlled trial. J Trop Pediatr. 2013;59:17-22.
73.
TanigasalamV, PlakkalN, Vishnu BhatB, ChinnakaliP.Does fluid restriction improve outcomes n infants with hypoxic ischemic encephalopathy? A pilot randomized controlled trial. J Perinatol. 2018;38:1512-1517.
74.
ThomasN, AbiramalathaT, BhatVet al.Phase changing material for therapeutic hypothermia in neonates with hypoxic ischemic encephalopathy—a multi-centric study. Indian Pediatr. 2018;55:201-205.
75.
Cuevas GuamanM, LuckeAM, HaganJL, KaiserJR.Bleeding complications and mortality in neonates receiving therapeutic hypothermia and extracorporeal membrane oxygenation. Am J Perinatol. 2018;35:271-276.
76.
ThomasN, AbiramalathaT, BhatVet al.Phase changing material for therapeutic hypothermia in neonates with hypoxic ischemic encephalopathy—a multi-centric study. Indian Pediatr. 2018;55:201-205.
77.
RabanMS, HarrisonMC.Fresh frozen plasma use in a neonatal unit in South Africa. J Trop Pediatr. 2015;61:266-271.
78.
AltuntasN, YenicesuI, BekenSet al.Clinical use of fresh-frozen plasma in neonatal intensive care unit. Transfus Apher Sci. 2012;47:91-94.
79.
GrossSJ, FilstonHC, AndersonJC.Controlled study of treatment for disseminated intravascular coagulation in the neonate. J Pediatr. 1982;100:445-448.
80.
TurnerT, ProwseCV, PrescottRJ, CashJD.A clinical trial on the early detection and correction of haemostatic defects in selected high-risk neonates. Br J Haematol. 1981;47:65-75.
DaniC, PoggiC, CeciariniF, BertiniG, PratesiS, RubaltelliFF.Coagulopathy screening and early plasma treatment for the prevention of intraventricular hemorrhage in preterm infants. Transfusion. 2009;49:2637-2644.
83.
CatfordK, MuthukumarP, ReddyC, Al AtrashH, ClarkeP, VenkateshV.Routine neonatal coagulation testing increases use of fresh-frozen plasma. Transfusion. 2014;54:1444-1445.
